Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized trial of OPC-67683 in pulmonary multidrug-resistant tuberculosis
2007-005229-31Phase 2Completed
- Sponsor
- Otsuka Holdings
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of delamanid in pulmonary tuberculosis (TB) (3 arms), sponsored by Otsuka Holdings. Started Dec 2007; status: completed.
02
Drugs
delamanid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on 2007-005229-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005229-31.